[go: up one dir, main page]

ZA856482B - Hot melt antihistamine formulations - Google Patents

Hot melt antihistamine formulations

Info

Publication number
ZA856482B
ZA856482B ZA856482A ZA856482A ZA856482B ZA 856482 B ZA856482 B ZA 856482B ZA 856482 A ZA856482 A ZA 856482A ZA 856482 A ZA856482 A ZA 856482A ZA 856482 B ZA856482 B ZA 856482B
Authority
ZA
South Africa
Prior art keywords
hot melt
antihistamine formulations
antihistamine
formulations
melt
Prior art date
Application number
ZA856482A
Other languages
English (en)
Inventor
Roger Withington
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of ZA856482B publication Critical patent/ZA856482B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA856482A 1984-08-30 1985-08-26 Hot melt antihistamine formulations ZA856482B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US64617984A 1984-08-30 1984-08-30

Publications (1)

Publication Number Publication Date
ZA856482B true ZA856482B (en) 1986-05-28

Family

ID=24592083

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA856482A ZA856482B (en) 1984-08-30 1985-08-26 Hot melt antihistamine formulations

Country Status (19)

Country Link
EP (1) EP0173293B1 (fr)
JP (1) JPH0621068B2 (fr)
KR (1) KR920007832B1 (fr)
AR (1) AR242341A1 (fr)
AT (1) ATE68972T1 (fr)
AU (1) AU579177B2 (fr)
CA (1) CA1250526A (fr)
DE (1) DE3584557D1 (fr)
DK (1) DK164642C (fr)
ES (1) ES8608866A1 (fr)
FI (1) FI87992C (fr)
GR (1) GR852078B (fr)
HU (1) HU195421B (fr)
IE (1) IE58080B1 (fr)
IL (1) IL76237A (fr)
NZ (1) NZ213248A (fr)
PH (1) PH21083A (fr)
PT (1) PT81028B (fr)
ZA (1) ZA856482B (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8507779D0 (en) * 1985-03-26 1985-05-01 Fujisawa Pharmaceutical Co Drug carrier
AR240018A1 (es) * 1987-10-07 1990-01-31 Merrell Pharma Inc Procedimiento para preparar una composicion que comprende derivados de piperidinoalcanol.
AR245888A1 (es) * 1989-01-23 1994-03-30 Merrell Pharma Inc Procedimiento para la preparacion de una composicion farmaceutica liquida de derivados de piperidinoalcanol.
EP0416585B1 (fr) * 1989-09-07 1996-06-05 Fuji Photo Film Co., Ltd. Procédé de traitement d'un matériau photographique en couleur à l'halogénure d'argent
US5270064A (en) * 1991-04-12 1993-12-14 Avian Allure Encapsulated food product with readily removable capsule
US5455045A (en) * 1993-05-13 1995-10-03 Syntex (U.S.A.) Inc. High dose formulations
GB2281697A (en) * 1993-09-14 1995-03-15 Euro Celtique Sa Laxative compositions in capsules
PT812195E (pt) * 1995-02-28 2003-03-31 Aventis Pharma Inc Composicao farmaceutica para compostos de piperidinoalcanol
US5574045A (en) * 1995-06-06 1996-11-12 Hoechst Marion Roussel, Inc. Oral pharmaceutical composition of piperidinoalkanol compounds in solution form
HU224921B1 (hu) * 1997-08-26 2006-04-28 Aventis Pharma Inc Vérbõséget csökkentõ piperidinoszármazékot kombinációban tartalmazó gyógyszerkészítmény
AUPP279698A0 (en) * 1998-04-03 1998-04-30 Sunscape Developments Limited Sustained release formulation
FR2838349B1 (fr) * 2002-04-15 2004-06-25 Laurence Paris Compositions liquides pour capsules molle a liberation prolongee et leur procede de fabrication
ATE359777T1 (de) * 2002-12-17 2007-05-15 Abbott Gmbh & Co Kg Fenofibratsäure enthaltende pharmazeutische zusammensetzung und deren physiologisch verträgliche salze und derivate
EP1832285A1 (fr) * 2002-12-17 2007-09-12 Abbott GmbH & Co. KG Formulation comprenant de l'acide fénofibrique ou l'un de ses sels physiologiquement acceptable
EP2042165A1 (fr) * 2007-09-28 2009-04-01 Swiss Caps Rechte und Lizenzen AG Capsules molles remplies avec un excipient thermofusible
FR2999937B1 (fr) * 2012-12-21 2015-01-09 Sanofi Sa Unite solide a haute teneur en fexofenadine et son procede de preparation
US20170119680A1 (en) 2015-10-30 2017-05-04 R.P. Scherer Technologies, Llc Extended release film-coated capsules

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3139383A (en) * 1961-06-26 1964-06-30 Norton Co Encapsulated time release pellets and method for encapsulating the same
US3878217A (en) * 1972-01-28 1975-04-15 Richardson Merrell Inc Alpha-aryl-4-substituted piperidinoalkanol derivatives
GB2118040A (en) * 1982-02-15 1983-10-26 Hoechst Uk Ltd Oral anti-diabetic preparation
DE3237814A1 (de) * 1982-10-12 1984-04-12 Warner-Lambert Co., 07950 Morris Plains, N.J. Wasserfreie emulsionen und verwendung derselben

Also Published As

Publication number Publication date
FI853275L (fi) 1986-03-01
NZ213248A (en) 1988-07-28
GR852078B (fr) 1985-12-30
IE852134L (en) 1986-02-28
KR920007832B1 (ko) 1992-09-18
FI853275A0 (fi) 1985-08-27
DE3584557D1 (de) 1991-12-05
PH21083A (en) 1987-07-16
DK164642C (da) 1992-12-14
KR870001830A (ko) 1987-03-28
CA1250526A (fr) 1989-02-28
EP0173293A2 (fr) 1986-03-05
FI87992C (fi) 1993-03-25
EP0173293A3 (en) 1987-07-01
PT81028A (en) 1985-09-01
JPH0621068B2 (ja) 1994-03-23
JPS6160613A (ja) 1986-03-28
ATE68972T1 (de) 1991-11-15
AR242341A1 (es) 1993-03-31
ES8608866A1 (es) 1986-07-16
IE58080B1 (en) 1993-06-30
HUT38248A (en) 1986-05-28
AU4669285A (en) 1986-03-06
AU579177B2 (en) 1988-11-17
EP0173293B1 (fr) 1991-10-30
DK384985D0 (da) 1985-08-23
FI87992B (fi) 1992-12-15
HU195421B (en) 1988-05-30
DK384985A (da) 1986-03-01
IL76237A0 (en) 1986-01-31
DK164642B (da) 1992-07-27
ES546545A0 (es) 1986-07-16
IL76237A (en) 1989-01-31
PT81028B (pt) 1987-09-18

Similar Documents

Publication Publication Date Title
GB8520632D0 (en) Plasmid
GB2212812B (en) Hot melt adhesive
AR242341A1 (es) Procedimiento para preparar una composicion farmaceutica conteniendo terfenadina como agente activo, ablandable por el calor y util para llenar capsulas en estado fundido.
DE3572606D1 (en) Melt dispensers
GB8419302D0 (en) Melt dispensers
HK43194A (en) Amorphous-polypropylene-based hot melt adhesive
GB8514851D0 (en) Hot melt dispensers
GB8428952D0 (en) Formulations
KR960008487B1 (en) Hot melt adhesive
ZA852603B (en) 2-(alkoximinoalkoxycarbonyl)-phenylsulphonylureas
AU574178B2 (en) Hot melt dispenser
GB2159154B (en) Methyl 2-(2-hydroperoxy-2-propyl)naphthalene-6-carboxylate
GB8427038D0 (en) Melting system
GB8425778D0 (en) Plasmid
GB8521221D0 (en) Controlled release formulations
CS227484A1 (en) Zpusob vyroby tlumiciho plaste
GB8511479D0 (en) Optical pyrometer
SU1172904A1 (ru) "oгheупop"
GB8502491D0 (en) Radiometer
CS975884A1 (en) Okenni dilec lehkeho obvodoveho plaste se samonosnym zakladnim ramenem
GB8428951D0 (en) Formulations
CS874784A1 (en) Zpusob vyroby plaste spradaciho rotoru
IL91636A0 (en) Plasmid pcz101
IE840096L (en) Plasmid pfr400
GB8408344D0 (en) Thermocouples